Literature DB >> 10543641

Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital.

M T Edwards1, M M Murphy, J J Geraghty, J A Wulf, J P Konzen.   

Abstract

BACKGROUND AND
PURPOSE: Advances in thrombolytic therapy, brain imaging, and neurointerventional techniques provide new therapeutic options for acute stroke. Intra-arterial thrombolysis has proved to be a potent therapeutic tool. To show that this procedure can be performed in community hospitals, we describe our experience with a group of 11 patients treated for middle cerebral artery occlusions.
METHODS: Twenty-two patients seen during a period of 1 year with clinical findings of acute major-vessel stroke met screening criteria and were evaluated under an institutional review board-approved protocol. After CT scanning, 17 of those patients met strict criteria, gave informed consent, and underwent angiography. Eleven patients had M1 and M2 middle cerebral artery occlusions and received local thrombolytic therapy with urokinase. Recanalization efficacy, complications, and outcome data were compiled.
RESULTS: The average score on the National Institutes of Health Stroke Scale was 22.2 at the onset of treatment and 12.5 after therapy, with 91% of patients showing neurologic improvement. Complete (TIMI 3) recanalization occurred in 73% of cases and partial recanalization (TIMI 2) in 18%. At the 90-day follow-up evaluation, 56% of patients had good outcomes (modified Rankin score, 0 to 1). One intracranial hemorrhage occurred.
CONCLUSION: Intra-arterial thrombolysis can be performed in a community hospital by radiologists with interventional and neuroradiologic skills given appropriate institutional preparation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543641

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

1.  Effect of CT acquisition parameters in the detection of subtle hypoattenuation in acute cerebral infarction: a phantom study.

Authors:  C Tanaka; T Ueguchi; E Shimosegawa; N Sasaki; T Johkoh; H Nakamura; J Hatazawa
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  Balloon catheter disruption of middle cerebral artery thrombus in conjunction with thrombolysis for the treatment of acute middle cerebral artery embolism.

Authors:  I Ikushima; H Ohta; T Hirai; K Yokogami; D Miyahara; N Maeda; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

Review 3.  Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements.

Authors:  K K Pulicherla; Mahendra Kumar Verma
Journal:  AAPS PharmSciTech       Date:  2015-01-23       Impact factor: 3.246

4.  Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.

Authors:  Peter Kraft; Tobias Schwarz; Joost C M Meijers; Guido Stoll; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

5.  Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation.

Authors:  Argyro Tountopoulou; Bjoern Ahl; Karin Weissenborn; Hartmut Becker; Friedrich Goetz
Journal:  Neuroradiology       Date:  2007-10-05       Impact factor: 2.804

6.  Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory.

Authors:  Takatoshi Sorimachi; Yukihiko Fujii; Naoto Tsuchiya; Takeo Nashimoto; Atsuko Harada; Yasushi Ito; Ryuichi Tanaka
Journal:  AJNR Am J Neuroradiol       Date:  2004-09       Impact factor: 3.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.